Remed Co.,Ltd. (KOSDAQ:302550)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,795.00
+20.00 (0.72%)
At close: Jan 23, 2026

Remed Revenue

Remed had revenue of 5.81B KRW in the quarter ending September 30, 2025, a decrease of -3.69%. This brings the company's revenue in the last twelve months to 24.26B, up 3.56% year-over-year. In the year 2024, Remed had annual revenue of 25.55B with 37.86% growth.

Revenue (ttm)
24.26B
Revenue Growth
+3.56%
P/S Ratio
3.56
Revenue / Employee
263.65M
Employees
92
Market Cap
86.39B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202425.55B7.02B37.86%
Dec 31, 202318.54B-2.83B-13.23%
Dec 31, 202221.36B1.17B5.79%
Dec 31, 202120.20B3.56B21.42%
Dec 31, 202016.63B-1.92B-10.34%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
DRTECH120.30B
Genoray102.75B
DRGEM98.34B
JPI Healthcare52.79B
CU Medical Systems44.79B
Hironic33.18B
SELVAS Healthcare29.79B
Neofect20.50B
Revenue Rankings